10x Genomics to Report Third Quarter 2023 Financial Results on November 2, 2023

PLEASANTON, Calif., Oct. 11, 2023 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today it will report financial results for the third quarter 2023 after market close on Thursday, November 2, 2023. The company will host a conference call and live webcast for analysts and investors beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. The news release with the financial results will be accessible from the company’s website prior to the conference call.

Live audio of the webcast will be available on the “Investors” section of the company website at: www.10xgenomics.com. The webcast will be archived and available for replay for at least 45 days after the event.
About 10x Genomics
10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world’s understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn or X (Twitter).
Disclosure Information
10x Genomics uses filings with the Securities and Exchange Commission, our website (www.10xgenomics.com), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.
Contacts Investors: investors@10xgenomics.com Media: media@10xgenomics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-report-third-quarter-2023-financial-results-on-november-2-2023-301954065.html
SOURCE 10x Genomics, Inc 

PLEASANTON, Calif., Oct. 11, 2023 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today it will report financial results for the third quarter 2023 after market close on Thursday, November 2, 2023. The company will host a conference call and live webcast for analysts and investors beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. The news release with the financial results will be accessible from the company’s website prior to the conference call.

Live audio of the webcast will be available on the “Investors” section of the company website at: www.10xgenomics.com. The webcast will be archived and available for replay for at least 45 days after the event.

About 10x Genomics

10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world’s understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn or X (Twitter).

Disclosure Information

10x Genomics uses filings with the Securities and Exchange Commission, our website (www.10xgenomics.com), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.

Contacts 
Investors: investors@10xgenomics.com 
Media: media@10xgenomics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-report-third-quarter-2023-financial-results-on-november-2-2023-301954065.html

SOURCE 10x Genomics, Inc

 

Spread The Word...

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

LATEST POST

Correction: Solutions30, through its subsidiary Unit-T, is selected to support Fluvius in their ´Energy Grid upgrade program´ in Flanders with a 5-year contract, extendable for another 3 years
Correction: Solutions30, through its subsidiary Unit-T, is selected to support Fluvius in their ´Energy Grid upgrade program´ in Flanders with a 5-year contract, extendable for another 3 years
NowVertical Group Announces Amendment to Acrotrend Obligations
NowVertical Group Announces Amendment to Acrotrend Obligations
Air Force selects Stratom to develop machine learning-driven system for asset tracking
Air Force selects Stratom to develop machine learning-driven system for asset tracking
ibex Named to Forbes Best Employers for Diversity 2024
ibex Named to Forbes Best Employers for Diversity 2024
The Bitcoin-Effect: How the Post-Halving Bitcoin Effect Can Take BlockDAG Network to $10 in 2025
The Bitcoin-Effect: How the Post-Halving Bitcoin Effect Can Take BlockDAG Network to $10 in 2025
Analytixinsight Announces Anticipated Delay in Filing Its Annual Audited Financial Statements
Analytixinsight Announces Anticipated Delay in Filing Its Annual Audited Financial Statements

CONTRIBUTE

Please contribute and support me to keep this website alive. Any BIG or small amount contributed is very much appreciated.

Thank you!